• Mithra signs LSA for commercialization of Estelle® in North Africa

    Monday October 19th 2020

  • CANNOVEX receives EUR 0.5 million grant for development of nanofibrous films for transmucosal uptake of cannabinoids

    Monday October 19th 2020

  • Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

    Friday October 16th 2020

  • New players at the synapse

    Friday October 16th 2020

  • Sequana Medical appoints two additional experts as Heart Failure Scientific Advisors

    Thursday October 15th 2020

  • Prof. Sarah-Maria Fendt is awarded the EMBO Gold Medal

    Thursday October 15th 2020

  • Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer

    Wednesday October 14th 2020

  • Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion

    Wednesday October 14th 2020

  • Your news here?

  • Phase 2B/3 Trial shows efficacy of Filgotinib for the induction and maintenance of remission in moderately and severely active Ulcerative Colitis

    Tuesday October 13th 2020

  • Sanquin finds investors for plasma-derived medicines manufacturing subsidiaries Plasma Industries and Plasma Products

    Tuesday October 13th 2020

  • BISC Global awarded a Eurostars grant for the development of a machine learning based antigen discovery and T-cell epitope prediction software.

    Friday October 9th 2020


Strategic Partners